XML 45 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

Revenues (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Products:
Net revenues	$ 8,093,244	$ 10,258,132
Acetadote
Products:
Net revenues	2,721,086	7,251,995
Omeclamox-Pak
Products:
Net revenues	1,139,421	0
Kristalose
Products:
Net revenues	3,376,057	2,117,250
Vaprisol
Products:
Net revenues	298,332	0
Caldolor
Products:
Net revenues	502,398	410,424
Other
Products:
Net revenues	$ 55,950	$ 478,463

X

- Details

Name:	cpix_ProductsAbstract
Namespace Prefix:	cpix_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration